Taylor Wealth Management Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$3.53M	Sell	24,190 -1,866	-7%	-$265K	2%	21
2022 Q1	$4.25M	Sell	26,056 -1,077	-4%	-$164K	1.72%	26
2021 Q4	$4.6M	Sell	27,133 -696	-3%	-$129K	1.62%	26
2021 Q3	$5.25M	Sell	27,829 -711	-2%	-$133K	1.87%	22
2021 Q2	$4.84M	Sell	28,540 -1,073	-4%	-$157K	1.71%	26
2021 Q1	$4.18M	Sell	29,613 -1,021	-3%	-$154K	1.53%	26
2020 Q4	$3.98M	Buy	30,634 +6	+0%	+$801	1.53%	26
2020 Q3	$4.46M	Buy	30,628 +744	+2%	+$106K	2.04%	19
2020 Q2	$4.43M	Sell	29,884 -3,836	-11%	-$517K	2.25%	16
2020 Q1	$3.67M	Buy	+33,720	New	+$3.89M	2.25%	17
2019 Q1	–	Sell	-80	Closed	-$6K	–	49
2018 Q4	$6K	Hold	80	–	–	﹤0.01%	98
2018 Q3	$7K	Hold	80	–	–	﹤0.01%	109
2018 Q2	$8K	Hold	80	–	–	﹤0.01%	115
2018 Q1	$10K	Hold	80	–	–	﹤0.01%	101
2017 Q4	$10K	Sell	80 -50	-38%	-$6.28K	﹤0.01%	127
2017 Q3	$15K	Hold	130	–	–	0.01%	121
2017 Q2	$10K	Hold	130	–	–	﹤0.01%	133
2017 Q1	$7K	Hold	130	–	–	﹤0.01%	139
2016 Q4	$5K	Hold	130	–	–	﹤0.01%	144
2016 Q3	$9K	Sell	130 -20	-13%	-$1.41K	﹤0.01%	130
2016 Q2	$8K	Sell	150 -75	-33%	-$4.72K	﹤0.01%	122
2016 Q1	$14K	Sell	225 -30,980	-99%	-$2.06M	0.01%	107
2015 Q4	$2.94M	Buy	31,205 +85	+0.3%	+$7.88K	1.27%	28
2015 Q3	$2.5M	Sell	31,120 -478	-2%	-$53.1K	1.21%	28
2015 Q2	$3.79M	Sell	31,598 -3	-0%	-$359	1.21%	34
2015 Q1	$3.3M	Buy	+31,601	New	+$3.2M	1.04%	38